Top Marijuana Shares regarding the NASDAQ

Even though the most of U.S.-based cannabis organizations and lots of foreign American Depository Receipts (ADRs) trade throughout the countertop (OTC), a marijuana that is few are exchanged in the NASDAQ. Some investors choose shares which can be noted on the NASDAQ with other exchanges because of the increased liquidity and tighter spreads set alongside the markets that are over-the-counter. As an example, due to the fact cannabis industry is continuing to grow in present months and years, uplisting from an OTC market to an established U.S. change is now a banner achievement for all marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

An number that is increasing of organizations are now being noted on reputable U.S. exchanges in the place of being exchanged regarding the OTC market showing the quick growth of the cannabis industry.

NASDAQ-listed Marijuana Stocks

The NASDAQ ended up being the initial exchange that is electronic is definitely synonymous with technology and biotechnology. The cannabis organizations regarding the NASDAQ mirror this, additionally the most of them operate into the area that is biotech of industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical purchase, at the time of October 26, 2019, with a dysfunction of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is a biotech business mixed up in production of medical marijuana medications. Research and development around Arena’s APD371 may be the primary focus regarding the firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is really a blank check business that is currently in a merger agreement with Kalyx developing Inc. Kalyx is a respected owning a home rely upon the regulated cannabis industry in the usa.

Key Takeaways

  • The cannabis industry, especially the part of cannabis and biotech, is attracting significant investor attention.
  • Cannabis has been used in brand new medications for the treating discomfort and numerous chronic, inflammatory, and fibrotic conditions.
  • Organizations will also be developing cannabinoid items for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (a hereditary disorder), and amphetamine addiction.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology business focused on developing and commercializing chemical that is new when it comes to indications of discomfort and pruritus (itching). Although all the firm’s clinical-stage items target opioid receptors, Cara is conducting research that is preclinical cannabinoids to treat neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is a cannabis biotech business. The team’s research, development, and manufacturing are based around cannabis medications that look for to take care of chronic, inflammatory, fibrotic, and other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is a cannabis that are canadian. The team has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced plans to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra money to invest in its continued expansion but in addition having a well-established partner skilled within the advertising of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis usage accessories and vaporization gear and items to customers that are retail the U.S. and Canada. Also, it runs websites that are e-commerce extra product sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is developing a profile of cannabinoid medications. These medications include Sativex to treat spasticity regarding multiple sclerosis and cancer tumors discomfort and Epidiolex to treat youth epilepsy. Sativex is commercialized in more than the usual dozen nations outside of the usa and has now gotten regulatory approval in various other nations. Epidiolex received Food And Drug Administration approval as being a treatment plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of severe, early beginning epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing cannabinoid items for autism range problems, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical company that is developing medications predicated on its proprietary Accordion Pill technology. Intec’s product pipeline includes cannabinoid-based drugs for lower back pain and fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based management that is pest plant health services and products. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now appropriate to be used on cannabis plants within the Ca cultivation market.

Modern Beverages Corp. (NASDAQ:NBEV)

Modern Beverages Corp. is just a manufacturer of beverages produced from yerba mate, green tea extract, kombucha, and comparable items. In present months, modern age has expanded its beverage offerings to add CBD infusions aswell, bringing it in to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted regarding the NASDAQ in might of 2019, which makes it the most current cannabis businesses to record in the popular trade. The organization was quickly expanding its production ability and may even manage to create just as much as 113,000 kilograms of product per 12 months by the end of 2019.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation runs when you look at the enforcement sector. The business’s business operations support medication screening through hair examples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is another brand new entry on the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a quick cost boost) whenever it announced the production of an innovative new Palmetto model of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is a specialty clinical-stage company that is pharmaceutical from the growth of cannabinoid-based medications. Therapix’s present pipeline includes items targeted to treat Tourette problem and mild intellectual disability.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being the initial cdb oil company that is marijuana-related have a preliminary public providing (IPO) in the usa. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis services and products.

Village Farms Global (NASDAQ:VFF)

Village Farms Overseas is one of recent cannabis stock to begin dealing from the NASDAQ. The business’s stocks became readily available for trade on 21, 2019 february. The business includes a history that is decades-long greenhouse produce production and it has just recently shifted a number of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted from the growth of synthetic treatments that are cannabinoid transdermal (through your skin) distribution. Their pipeline presently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic pain, and Fragile X syndrome.